We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Susan Sadighi
Nov 30, 2022
Based on imaging and tumor marker reports, I believed letrozole worked very well in this case. We can preserve CDK 4/6 Inh. if the metastases show progression. Since the patient has no symptoms and we can not exclude lung metastasis, I do not agree with neck radiation too.
Amiy Arnav
Jan 07, 2023
In view of the prolonged disease-free survival and good response to Letrozole, I will suggest continuing the current management and reserve CDK4/6 Inhb for progression. Radiation may not be of much use to us.
Dec 22, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Susan Sadighi
Nov 30, 2022
Amiy Arnav
Jan 07, 2023
Dec 22, 2024
Pending Moderator approval.